Seastar Medical Hldg Corp (ICU) Stock Price, Quote & News

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI)...

Industry: Biotechnology

Sector: Healthcare

Phone: 844 427 8100

Website: seastarmedical.com

Address:

3513 Brighton Boulevard, Suite 410, Denver, United States

Yi_YandH Apr. 14 at 9:50 PM

$ICU CMO Chung.

0 · Reply

BULLISH1975 Apr. 14 at 6:58 PM

$ICU holding strong, We consolidating in wait of more news and update. many here are loaded! I expect lots of good news all year! Huge progress being made! still under the radar! big money is not hiving retail an easy straight fwd 45% chart!!!! very bullish!!! just a matter of when we break $5 and then $10 in a couple weeks or months!!! dyor

0 · Reply

Tomasini Apr. 14 at 6:55 PM

$ICU shorts and mms having fun on low volume. need news/buyers

1 · Reply

Perillo1984 Apr. 14 at 5:53 PM

$ICU 🤡👇

1 · Reply

Nikki7220 Apr. 14 at 4:51 PM

$ICU Very LOW volume. Will be much higher. Over 6% down in 1 day is not normal. Let the profit takers and stop losses done.

1 · Reply

GoldenPalaceTrades Apr. 14 at 4:18 PM

If you like jumping in to them runners before they breakout... I would recommend Following that @ElevenXProfits guy below, Great trader, He's been on point with his entries 💯🔥 Adding profit to $IBRX $BBAI $ICU $ORBS swings

0 · Reply

ALOSETE Apr. 14 at 3:47 PM

$ICU smelling news.

0 · Reply

Blastus Apr. 14 at 2:43 PM

$ICU The blind bulls can't see this is still in the hourly downtrend channel and still in the daily downtrend channel. This will hit 3.30 range and possibly 2.70 after that. If you're blind and can't see, at least listen and wait to add until those levels.

2 · Reply

SparkyReturns Apr. 14 at 2:38 PM

$ICU I think they'll be fine with rolling out the SCD for AKI with Fresenius, but I hope they get another partner for the LVAD indication or another cytokine storm indication, that would be amazing. That's also a multi-Billion $ TAM. Someone like Medtronic, Edwards, Abbot, or Boston Scientific. GL longs! We are at the inflection point. $MDT $EW $ABT $BSX

0 · Reply

marvessa Apr. 14 at 2:11 PM

$ICU selling now is stupid , hold it and forget it

0 · Reply

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Mar 25, 2026, 4:05 PM EDT - 20 days ago

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Mar 18, 2026, 4:05 PM EDT - 27 days ago

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

Mar 9, 2026, 8:35 AM EDT - 5 weeks ago

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

Mar 5, 2026, 8:20 AM EST - 5 weeks ago

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

Feb 9, 2026, 8:20 AM EST - 2 months ago

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Jan 29, 2026, 8:25 AM EST - 2 months ago

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

Jan 7, 2026, 8:13 AM EST - 3 months ago

SeaStar Medical Announces 2026 Milestones

Jan 6, 2026, 8:53 AM EST - 3 months ago

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

Dec 23, 2025, 4:25 PM EST - 4 months ago

SeaStar Medical Announces 1-for-10 Reverse Split

Dec 2, 2025, 8:27 AM EST - 4 months ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Nov 20, 2025, 9:52 AM EST - 5 months ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

Nov 17, 2025, 8:43 AM EST - 5 months ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

Nov 13, 2025, 4:05 PM EST - 5 months ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 5, 2025, 10:03 AM EST - 5 months ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Sep 29, 2025, 8:36 AM EDT - 7 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Sep 24, 2025, 4:22 PM EDT - 7 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Sep 23, 2025, 8:23 AM EDT - 7 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

Sep 4, 2025, 6:13 PM EDT - 7 months ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:22 AM EDT - 8 months ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Aug 13, 2025, 4:05 PM EDT - 8 months ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 7, 2025, 10:00 AM EDT - 8 months ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

Aug 6, 2025, 8:33 AM EDT - 8 months ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Jul 31, 2025, 3:01 PM EDT - 9 months ago

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 22, 2025, 8:20 AM EDT - 9 months ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 16, 2025, 8:45 AM EDT - 9 months ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Jul 10, 2025, 3:29 PM EDT - 9 months ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 8, 2025, 8:05 AM EDT - 10 months ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Jul 2, 2025, 4:25 PM EDT - 10 months ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

Jun 25, 2025, 8:05 AM EDT - 10 months ago

SeaStar Medical Reports Update on Nasdaq Listing Status

Jun 24, 2025, 9:05 AM EDT - 10 months ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Jun 20, 2025, 12:10 PM EDT - 10 months ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Jun 11, 2025, 8:25 AM EDT - 10 months ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

May 28, 2025, 8:05 AM EDT - 11 months ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

May 14, 2025, 4:05 PM EDT - 11 months ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

May 13, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

May 7, 2025, 10:00 AM EDT - 1 year ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

Apr 30, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Apr 8, 2025, 8:05 AM EDT - 1 year ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Mar 27, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 24, 2025, 5:30 PM EDT - 1 year ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 18, 2025, 8:45 AM EDT - 1 year ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Feb 3, 2025, 4:05 PM EST - 1 year ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

Jan 22, 2025, 7:30 AM EST - 1 year ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

Jan 13, 2025, 8:30 AM EST - 1 year ago

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Jan 8, 2025, 8:30 AM EST - 1 year ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

Dec 23, 2024, 7:00 AM EST - 1 year ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

Dec 11, 2024, 6:30 AM EST - 1 year ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

Dec 4, 2024, 8:30 AM EST - 1 year ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024

Yi_YandH Apr. 14 at 9:50 PM

$ICU CMO Chung.

0 · Reply

BULLISH1975 Apr. 14 at 6:58 PM

0 · Reply

Tomasini Apr. 14 at 6:55 PM

$ICU shorts and mms having fun on low volume. need news/buyers

1 · Reply

Perillo1984 Apr. 14 at 5:53 PM

$ICU 🤡👇

1 · Reply

Nikki7220 Apr. 14 at 4:51 PM

$ICU Very LOW volume. Will be much higher. Over 6% down in 1 day is not normal. Let the profit takers and stop losses done.

1 · Reply

GoldenPalaceTrades Apr. 14 at 4:18 PM

0 · Reply

ALOSETE Apr. 14 at 3:47 PM

$ICU smelling news.

0 · Reply

Blastus Apr. 14 at 2:43 PM

2 · Reply

SparkyReturns Apr. 14 at 2:38 PM

0 · Reply

marvessa Apr. 14 at 2:11 PM

$ICU selling now is stupid , hold it and forget it

0 · Reply

Tomasini Apr. 14 at 2:11 PM

$ICU only thing missing is revenue. they need a partner with big pharma

1 · Reply

SparkyReturns Apr. 14 at 1:53 PM

$ICU

2 · Reply

ALOSETE Apr. 14 at 1:38 PM

$ICU Ready to go north. 4.5$ today.

0 · Reply

Aznwactrackstar Apr. 14 at 10:48 AM

$ICU what a close and what a premarket!

0 · Reply

bleedingcrypto Apr. 14 at 10:43 AM

$ICU i know they dont need to sell shares, but im saving my dry powder in case they do. That will be what I feel is ghe final dca. I hope im wrong but ive been here too long to not have ptsd from this management. My target is 125million mc regardless for 2027.

1 · Reply